Cas no 1008415-02-8 (3-Chloro-4-cyanophenylboronic Acid)

3-Chloro-4-cyanophenylboronic Acid is a boronic acid derivative featuring both chloro and cyano functional groups on the phenyl ring. This compound is widely utilized in Suzuki-Miyaura cross-coupling reactions due to its stability and reactivity, enabling the synthesis of complex biaryl structures. The presence of electron-withdrawing substituents enhances its utility in selective transformations, making it valuable in pharmaceutical and materials science research. Its crystalline form ensures consistent purity, while its compatibility with various reaction conditions broadens its applicability. The compound is typically handled under inert conditions to preserve its integrity, and its well-defined structure facilitates precise incorporation into target molecules.
3-Chloro-4-cyanophenylboronic Acid structure
1008415-02-8 structure
Product Name:3-Chloro-4-cyanophenylboronic Acid
CAS No:1008415-02-8
MF:C7H5BClNO2
MW:181.384100675583
MDL:MFCD11504841
CID:827691
PubChem ID:46738932
Update Time:2025-06-08

3-Chloro-4-cyanophenylboronic Acid Chemical and Physical Properties

Names and Identifiers

    • (3-Chloro-4-cyanophenyl)boronic acid
    • 3-Chloro-4-cyanophenylboronic acid
    • 4-Cyano-3-chlorophenylboronic acid
    • 3-Chloro-4-cyanophenylboronic Acid
    • MDL: MFCD11504841
    • Inchi: 1S/C7H5BClNO2/c9-7-3-6(8(11)12)2-1-5(7)4-10/h1-3,11-12H
    • InChI Key: QCJTUOIMDNJEHR-UHFFFAOYSA-N
    • SMILES: ClC1=C(C#N)C=CC(B(O)O)=C1

Computed Properties

  • Exact Mass: 181.01000
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 1

Experimental Properties

  • Density: 1.41±0.1 g/cm3 (20 oC 760 Torr),
  • Solubility: Very slightly soluble (0.53 g/l) (25 o C),
  • PSA: 64.25000
  • LogP: -0.10852

3-Chloro-4-cyanophenylboronic Acid Security Information

  • Hazard Category Code: 22
  • Hazardous Material Identification: Xn

3-Chloro-4-cyanophenylboronic Acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Fluorochem
219163-250mg
3-Chloro-4-cyanophenyl)boronic acid
1008415-02-8 95%
250mg
£163.00 2022-03-01
Fluorochem
219163-1g
3-Chloro-4-cyanophenyl)boronic acid
1008415-02-8 95%
1g
£325.00 2022-03-01
Fluorochem
219163-5g
3-Chloro-4-cyanophenyl)boronic acid
1008415-02-8 95%
5g
£1225.00 2022-03-01
TRC
C380683-25mg
3-Chloro-4-cyanophenylboronic Acid
1008415-02-8
25mg
$64.00 2023-05-18
TRC
C380683-50mg
3-Chloro-4-cyanophenylboronic Acid
1008415-02-8
50mg
$69.00 2023-05-18
TRC
C380683-100mg
3-Chloro-4-cyanophenylboronic Acid
1008415-02-8
100mg
$98.00 2023-05-18
TRC
C380683-250mg
3-Chloro-4-cyanophenylboronic Acid
1008415-02-8
250mg
$178.00 2023-05-18
Chemenu
CM128526-1g
(3-chloro-4-cyanophenyl)boronic acid
1008415-02-8 95%
1g
$117 2023-02-19
Chemenu
CM128526-5g
(3-chloro-4-cyanophenyl)boronic acid
1008415-02-8 95%
5g
$409 2023-02-19
Apollo Scientific
OR360914-1g
3-Chloro-4-cyanophenylboronic acid
1008415-02-8 0.97
1g
£90.00 2025-02-19

Additional information on 3-Chloro-4-cyanophenylboronic Acid

Introduction to 3-Chloro-4-cyanophenylboronic Acid (CAS No. 1008415-02-8)

3-Chloro-4-cyanophenylboronic Acid, identified by the Chemical Abstracts Service Number (CAS No.) 1008415-02-8, is a specialized organoboron compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound, characterized by its chloro and cyano substituents on a phenyl ring coupled with a boronic acid functional group, exhibits unique chemical properties that make it a valuable intermediate in synthetic chemistry and drug development.

The molecular structure of 3-Chloro-4-cyanophenylboronic Acid consists of a benzene ring substituted with a chlorine atom at the 3-position and a cyano group at the 4-position, with a boronic acid moiety attached to the 1-position. This arrangement imparts distinct reactivity, making it particularly useful in cross-coupling reactions such as the Suzuki-Miyaura coupling, which is widely employed in the synthesis of complex organic molecules, including pharmaceuticals.

In recent years, there has been a surge in research focused on boronic acid derivatives due to their role as key intermediates in the development of novel therapeutic agents. The presence of both electron-withdrawing cyano and electron-donating chloro groups on the phenyl ring enhances the reactivity of the boronic acid moiety, facilitating its participation in various chemical transformations. This has led to its incorporation into numerous synthetic protocols aimed at constructing biaryl structures, which are prevalent in many bioactive compounds.

One of the most notable applications of 3-Chloro-4-cyanophenylboronic Acid is in the field of medicinal chemistry. Researchers have leveraged its unique reactivity to develop novel inhibitors targeting various biological pathways. For instance, studies have demonstrated its utility in synthesizing small-molecule inhibitors for enzymes involved in cancer metabolism. The ability to precisely modify the phenyl ring through cross-coupling reactions allows for the generation of libraries of compounds with tailored biological activities, enabling high-throughput screening for drug discovery.

The cyano group in 3-Chloro-4-cyanophenylboronic Acid also contributes to its versatility as a synthetic building block. The cyano functionality can be further modified through reduction to an amine or hydrolyzed to a carboxylic acid, providing additional pathways for structural diversification. This adaptability has made it a preferred choice for medicinal chemists seeking to explore new chemical spaces for drug development.

Furthermore, the chloro substituent at the 3-position of the phenyl ring enhances the electrophilicity of the boronic acid moiety, making it more susceptible to nucleophilic attack during cross-coupling reactions. This property has been exploited in various synthetic strategies, including the construction of heterocyclic compounds and polyaromatic systems. Such structures are often found in biologically active molecules and have been shown to exhibit potent pharmacological effects.

Recent advancements in computational chemistry have also highlighted the potential of 3-Chloro-4-cyanophenylboronic Acid as a scaffold for drug discovery. Molecular modeling studies have revealed that derivatives of this compound can interact with biological targets through multiple binding modes, increasing their likelihood of success in clinical trials. These insights have guided the design of new analogs with improved pharmacokinetic properties and reduced off-target effects.

The synthesis of 3-Chloro-4-cyanophenylboronic Acid itself is an area of active research. While traditional methods involve multi-step organic transformations, recent reports have described more efficient synthetic routes that minimize waste and improve yields. These innovations align with broader trends in green chemistry, emphasizing sustainable practices in pharmaceutical manufacturing.

In conclusion, 3-Chloro-4-cyanophenylboronic Acid (CAS No. 1008415-02-8) represents a significant advancement in organoboron chemistry with far-reaching implications for drug development and materials science. Its unique structural features and reactivity make it an indispensable tool for synthetic chemists and medicinal chemists alike. As research continues to uncover new applications for this compound, its importance is expected to grow even further.

Recommended suppliers
SHOCHEM(SHANGHAI) CO.,lTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
SHOCHEM(SHANGHAI) CO.,lTD
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.